3-(hexyloxy)propan-1-ol | 132757-06-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-(hexyloxy)propan-1-ol
• 英文别名: propylene glycol monohexyl ether；3-hexoxypropan-1-ol
• CAS: 132757-06-3
• 化学式: C₉H₂₀O₂
• 分子量: 160.257
• InChiKey: RMUIGRZAEAVCIT-UHFFFAOYSA-N

物化性质

• 沸点：
  75-75.5 °C(Press: 0.8 Torr)
• 密度：
  0.885±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(hexyloxy)propan-1-ol 在 四丁基氢氧化铵 、 sodium hydroxide 作用下， 以 二乙二醇二甲醚 、 水 为溶剂， 反应 71.0h， 生成
  参考文献：
  名称：

  JP5760218

  摘要：

  公开号：
• 作为产物：
  描述：

  在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 生成 3-(hexyloxy)propan-1-ol
  参考文献：
  名称：

  Synthesis and antiproliferative activity of alkylphosphocholines

  摘要：

  Alkylphosphocholines (APC) with one or more methylene groups in the alkyl chain replaced by oxygen atoms or carbonyl groups, or both have been assembled modularly using w-diols as central building blocks. Out of 25 new compounds of this kind, I I were evaluated for their antiproliferative activity on four cell lines and compared with miltefosine to evaluate their hemolytic activity (HA); and cytotoxicity on non-tumoral cells (MT2), used as markers of adverse effects. Compound 13 was more active on cancer cell lines than on non-tumoral cells and the data were similar for MTT and thymidine incorporation assays. It had less HA than miltefosine, Compound 13 could therefore be a candidate for the preparation of compounds with higher cytotoxicity on cancer cells and lower general toxicity. (C) 2003 Elsevier Ireland Ltd. All rights reserved.

  DOI：

  10.1016/j.chemphyslip.2003.08.002

文献信息

• DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE AND PHARMACEUTICALS CONTAINING THE SAME
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：US20160002251A1

  公开（公告）日：2016-01-07

  The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification comprising the compound as an active ingredient, and a method for prevention and/or treatment.

  本发明提供了一种二氢吡啶嗪-3,5-二酮衍生物或其盐，或化合物或盐的溶剂化合物，一种药物，一种药物组合物，一种钠依赖性磷酸盐转运体抑制剂，以及作为活性成分的化合物的高磷血症、继发性甲状旁腺功能亢进症、慢性肾功能衰竭、慢性肾病和与血管钙化相关的动脉硬化的预防和/或治疗剂，以及预防和/或治疗的方法。
• [EN] CHIRAL ALKOXY ALCOHOLS, CHIRAL 1 ,3-PHENYLENE-B?S[4-(4-ALKOXY) PHENYLIMINOMETHYL] BENZOATES AND PROCESSES FOR PREPARATION THEREOF<br/>[FR] ALCOOLS ALCOXY CHIRAUX, 1,3-PHENYLENE-BIS[4-(4-ALCOXY)PHENYLIMINOMETHYL]BENZOATES CHIRAUX ET PROCEDES DE PREPARATION CORRESPONDANTS
  申请人：DONGJIN SEMICHEM CO LTD

  公开号：WO2006025687A1

  公开（公告）日：2006-03-09

  The present invention relates to chiral alkoxy alcohols, chiral 1 ,3- phenylene bιs[4-(4-alkoxy)phenylιmιnomethyl]benzoates, and the preparation methods of them In particular, the chiral alkoxy alcohol of the present invention can be used for synthesizing chiral liquid crystal materials, pharmaceuticals, agricultural chemicals, and as intermediates for natural product synthesis Since the chiral compound of 1 ,3-phenylene bιs[4-(4-alkoxy)- phenylιmιnomethyl]benzoate has a lower phase transition temperature and exhibit ferroelectricity or antiferroelectricity depending on the length of chiral (alkoxy)alkyl terminal group, it can be used as an important component in the mixture of smectic liquid crystal

  本发明涉及手性烷氧基醇，手性1,3-苯基双[4-(4-烷氧基)苯基亚甲基]苯甲酸酯，以及它们的制备方法。特别是，本发明的手性烷氧基醇可用于合成手性液晶材料、药物、农药，并作为天然产物合成的中间体。由于1,3-苯基双[4-(4-烷氧基)苯基亚甲基]苯甲酸酯的手性化合物具有较低的相变温度，并根据手性(烷氧基)烷基末端基团的长度表现出铁电性或反铁电性，因此它可以作为莎美酸液晶混合物中的重要组分。
• SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR
  申请人：JAPAN TOBACCO INC.

  公开号：US20140221378A1

  公开（公告）日：2014-08-07

  Provided is a substituted spiropyrido[1,2-a]pyrazine derivative or a pharmaceutically acceptable salt thereof, which is useful as an anti-HIV agent. The present invention relates to a compound represented by the following formula [I] or [II] or a pharmaceutically acceptable salt thereof: wherein each symbol is as defined in the specification.

  提供了一种替代的螺环吡啶并[1,2-a]吡嗪衍生物或其药用盐，其作为一种抗HIV药物。本发明涉及以下式[I]或[II]所表示的化合物或其药用盐： 其中每个符号如规范中定义的那样。
• [EN] METAL ORGANIC COMPOUNDS<br/>[FR] COMPOSÉS ORGANOMÉTALLIQUES
  申请人：UMICORE AG & CO KG

  公开号：WO2021197597A1

  公开（公告）日：2021-10-07

  The invention concerns a process for preparing an essentially silicon (Si) free compounds of the general formula [M(O)(OR)y], wherein M = Mo, y = 3 or M = W, y = 3 or 4. Furthermore, it is directed towards compounds obtained by the aforementioned process and towards the use of such an obtained compound. Another objective of the herein described invention are essentially silicon free compounds of the general formula MOXy or [MOXy(solv)p], prepared using the aforementioned process, wherein M = Mo, y = 3 or M = W, y = 3 or 4, X = Cl or Br, solv = an oxidizing agent Z binding or coordinating to M via at least one donor atom, p = 1 or 2. The invention is also directed towards the use of essentially silicon free compounds prepared using the aforementioned process of the general formula MOXy or [MOXy(solv)p].

  该发明涉及一种制备通式[M(O)(OR)y]的基本无硅（Si）化合物的过程，其中M = Mo，y = 3或M = W，y = 3或4。此外，它针对通过上述过程获得的化合物以及利用这种获得的化合物的用途。所述发明的另一个目标是使用上述过程制备的通式MOXy或[MOXy(solv)p]的基本无硅化合物，其中M = Mo，y = 3或M = W，y = 3或4，X = Cl或Br，solv = 通过至少一个供体原子与M结合或配位的氧化剂Z，p = 1或2。该发明还涉及利用利用上述通式MOXy或[MOXy(solv)p]的基本无硅化合物的方法。
• 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor
  申请人：MIYAZAKI Susumu

  公开号：US20120108564A1

  公开（公告）日：2012-05-03

  [Problem] Provided is a novel 1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine derivative or a pharmaceutically acceptable salt thereof, or a solvate thereof, which is useful as an anti-HIV agent. [Solving Means] The present invention provides a compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof.

  [问题] 提供了一种新颖的1,3,4,8-四氢-2H-吡啶并[1,2-a]吡嗪衍生物或其药学上可接受的盐，或其溶剂合物，该物质作为抗HIV药物具有应用价值。[解决方案] 本发明提供了一种由以下通式[I]表示的化合物，其中各个符号的定义如说明书中所述，或其药学上可接受的盐，或其溶剂合物。